Using our newly developed assay, we measured circulating concentrations of FH, FHL-1, and FHR-1 to FHR-5 in plasma samples of 352 individuals with advanced AMD and 252 phenotyped controls from the Cambridge AMD study26,27 (Table 1, Figure 2). The gene discussed is FHL1; the disease is age-related macular degeneration.